Clicky

LumiraDx Limited(LMDX)

Description: LumiraDx is a next-generation point of care diagnostics company that is transforming community-based healthcare. Founded in 2014, LumiraDx manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. LumiraDx diagnostic testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness as well as disease. LumiraDx has, on the market and in development, 30+ tests covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, all on the LumiraDx Platform. In addition, LumiraDx has a comprehensive portfolio of fast, accurate, and cost-efficient COVID-19 testing solutions from the lab to point of need.


Keywords: Medicine Life Sciences Disease Pharmacy Health Sciences Diabetes Infectious Diseases Cardiovascular Disease Medical Test Healthcare Institutions Diasorin Lake Bluff Covid 19 Testing Diagnostic Testing Solutions

Home Page: www.lumiradx.com

LMDX Technical Analysis

3 More London Riverside
London, SE1 2AQ
United Kingdom
Phone: 44 11 7284 2535


Officers

Name Title
Mr. Ron Zwanziger Co-Founder, Chairman & CEO
Dr. David Scott Ph.D. Co-Founder, CTO & Director
Dr. Jerome F. McAleer Ph.D. Co-Founder, Chief Scientist & Director
Mr. Dorian LeBlanc CPA CFO & VP of Global Operations
Ms. Veronique Ameye Exec. VP & Gen. Counsel
Ms. Colleen McMillen VP of Communications
Andy Ward National Sales Director - UK
Mr. Peter Scheu Pres of North American Commercial Operations
Mr. David Walton DMS Chief Commercial Officer
Dr. Nigel Lindner Chief Innovation Officer

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 8.838
Price-to-Book MRQ: 18.6266
Price-to-Sales TTM: 0.8814
IPO Date: 2021-09-28
Fiscal Year End: December
Full Time Employees: 1513
Back to stocks